NPK International Inc (NWP) Quote

muln..........................................................slaptheask.................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856

$BHAT .30, I was pounding the table at .12 & .13 and no one wanted it, lol

$SLRX + $QMMM + $SXTC NOW in pre on watch

$SLRX + $QMMM + $SXTC NOW in pre on watch

Big thing happening .29 + 134%

Probably tax loss selling

.30

MULN...........................................................slaptheask...............................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856

LPSN 1.63 MINI MONSTER

OPTT......RVSN.....SXTC....LITM.....MULN,...............................................,,,,p/m

“All you can say is that is that Merck and NWBO have not arrived at a mutually acceptable deal”.

— They never will. In fact, no big pharma is interested in NWBO. Forget about Merck.

If LP had the chops and if a big pharma was genuinely interested in DCVAX platform, big

Ready here phenomenal studies

https://stocktwits.com/SanDiegoLiving/message/598312288

.40

Everyone is fully aware and warned of scamming bashers so the smart folks continue to accumulate shares. Poor low life bashers 🤮😂

" Has the Bolt installation been completed, Bull " .. ??

That's how it's done bear it down merciless first 

16 million in share dilution incoming!!!! Read the filing. 

Dilution is awful. If you look at issuance table....it is not for expansion...shares are issued for toxic convertible notes converted by those who slam shares at will into bid (since some don't like term CDer).....and have been doing so for going on 4 years now

Bingo .37 

So all in all what’s your real take on this stock?

I just dislike posters making price predictions with zero basis for making such claims....it is called wishful thinking...which is fine but don't give the appearance of being fact based

Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

4.75

Breaking News for #Hedera 🚨
Breaking News for #Hedera 🚨

For the second consecutive month, Hedera has shattered records for both total n